Zobrazeno 1 - 10
of 246
pro vyhledávání: '"Afd Pharmacoepi & Clinical Pharmacology"'
Autor:
Wasylewicz, Arthur, van de Burgt, Britt, Weterings, Aniek, Jessurun, Naomi, Korsten, Erik, Egberts, Toine, Bouwman, Arthur, Kerskes, Marieke, Grouls, René, van der Linden, Carolien, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
British Journal of Clinical Pharmacology, 88(3), 1235. NLM (Medline)
British Journal of Clinical Pharmacology, 88(3), 1235-1245. Wiley-Blackwell
British Journal of Clinical Pharmacology, 88(3), 1235-1245. Wiley-Blackwell
Background: Adverse drug reactions (ADRs) are estimated to be the fifth cause of hospital death. Up to 50% are potentially preventable and a significant number are recurrent (reADRs). Clinical decision support systems have been used to prevent reADRs
Autor:
Wittermans, Esther, van der Zee, Philip A, Qi, Hongchao, van de Garde, Ewoudt M W, Blum, Claudine A, Christ-Crain, Mirjam, Gommers, Diederik, Grutters, Jan C, Voorn, G Paul, Bos, Willem Jan W, Endeman, Henrik, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
ERJ Open Research, 8(1):00489-2021. European Respiratory Society
ERJ Open Research, 8(1). EUROPEAN RESPIRATORY SOC JOURNALS LTD
ERJ Open Research, 8(1), 1. European Respiratory Society
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research, 8(1). EUROPEAN RESPIRATORY SOC JOURNALS LTD
ERJ Open Research, 8(1), 1. European Respiratory Society
ERJ Open Research
article-version (VoR) Version of Record
Background Latent class analysis (LCA) has identified subgroups with meaningful treatment implications in acute respiratory distress syndrome. We performed a secondary analysis of three studies to assess whether LCA can identify clinically distinct s
Autor:
Komen, Joris, Pottegård, Anton, Hjemdahl, Paul, Mantel-Teeuwisse, Aukje K., Wettermark, Björn, Hellfritzsch, Maja, Hallas, J., Herings, Ron, Smits, Lisa, Forslund, Thomas, Klungel, Olaf, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Komen, J, Pottegard, A, Hjemdahl, P, Mantel-Teeuwisse, A K, Wettermark, B, Hellfritzsch, M, Hallas, J, Herings, R, Smits, L, Forslund, T & Klungel, O 2021, ' Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds ', Heart . https://doi.org/10.1136/heartjnl-2021-319332
Heart. BMJ Publishing Group
Heart, 108, 613. BMJ Publishing Group
Heart. BMJ Publishing Group
Heart, 108, 613. BMJ Publishing Group
ObjectiveTo evaluate if proton pump inhibitor (PPI) treatment reduces the risk of upper gastrointestinal bleeding (UGIB) in patients with atrial fibrillation (AF) treated with non-vitamin K antagonist oral anticoagulants (NOACs).DesignWe used a commo
Autor:
Bots, SH, Onland-Moret, NC, Tulevski, II, van, der Harst P, Cramer, MJM, Asselbergs, FW, Somsen, GA, den, Ruijter HM, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Heart
Heart (British Cardiac Society), 107(21), 1748-1755. BMJ Publishing Group
Heart (British Cardiac Society), 107(21), 1748
Heart (British Cardiac Society), 107(21), 1748-1755. BMJ Publishing Group
Heart (British Cardiac Society), 107(21), 1748
ObjectiveWomen with heart failure with reduced ejection fraction (HFrEF) may reach optimal treatment effect at half of the guideline-recommended medication dose. This study investigates prescription practice and its relation with survival of patients
Autor:
Broekhoff, Thomas F., Sweegers, Carly C.G., Krijkamp, Eline M., Mantel-Teeuwisse, Aukje K., Leufkens, Hubert G.M., Goettsch, Wim G., Vreman, Rick A., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Value in Health, 24(6), 759-769. Elsevier Ltd.
Value in Health, 24(6), 759. Elsevier Ltd
Value in Health, 24(6), 759. Elsevier Ltd
Objectives Onasemnogene Abeparvovec-xioi (AVXS-101) is a gene therapy intended for curative treatment of spinal muscular atrophy (SMA) with an expected price of around €2 000 000. The goal of this study is to perform a cost-effectiveness analysis o
Autor:
Narsai, K., Leufkens, H. G.M., Mantel-Teeuwisse, A. K., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1, Pp 1-10 (2021)
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice, 14(1), 1. BioMed Central
Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice, 14(1), 1. BioMed Central
Background Sub-Saharan Africa is going through an epidemiological transition, including an impressive increase in non-communicable diseases. The introduction of medicines has not kept pace with the needs in developing countries. The objectives of thi
Autor:
Kibira, Denis, Ssebagereka, Anthony, van den Ham, Hendrika A., Opigo, Jimmy, Katamba, Henry, Seru, Morries, Reed, Tim, Leufkens, Hubert G., Mantel-Teeuwisse, Aukje K., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-8 (2021)
Malaria Journal, 20(1), 1. BioMed Central
Malaria Journal
Malaria Journal, 20(1), 1. BioMed Central
Malaria Journal
Background Malaria is the single largest cause of illness in Uganda. Since the year 2008, the Global Fund has rolled out several funding streams for malaria control in Uganda. Among these are mechanisms aimed at increasing the availability and afford
Autor:
Cramer-Van der Welle, Christine M., Kastelijn, Elisabeth A., Plouvie, Bram C., Van Uden-Kraan, Cornelia F., Schramel, Franz M.N.H., Groen, Harry J.M., Van de Garde, Ewoudt M.W., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
JCO clinical cancer informatics, 5, 570-578. American Society of Clinical Oncology
JCO clinical cancer informatics, 5, 570. American Society of Clinical Oncology
JCO clinical cancer informatics, 5, 570. American Society of Clinical Oncology
PURPOSE To develop and evaluate a tool for patients with stage IV non–small-cell lung cancer and their thoracic oncologists (TOs) that provides insight into real-world effectiveness of systemic treatments to support informed clinical decision makin
Autor:
Minjon, Lenneke, van den Ban, Els, Bazelier, Marloes T, Lalmohamed, Arief, Egberts, Toine C G, Heerdink, Eibert R, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Journal of Child and Adolescent Psychopharmacology, 32(1), 36. Mary Ann Liebert inc
Journal of Child and Adolescent Psychopharmacology, 32(1), 36. Mary Ann Liebert Inc.
Journal of Child and Adolescent Psychopharmacology, 32(1), 36. Mary Ann Liebert Inc.
Objective: The aim of the study was to assess monitoring of adverse drug reaction (ADR)-related parameters in children, youth, and young adults treated with second-generation antipsychotic drugs (SGAs) prescribed by general practitioners (GPs). Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::154e98ab2d1aa1d324a7d50160a70470
https://dspace.library.uu.nl/handle/1874/419024
https://dspace.library.uu.nl/handle/1874/419024
Autor:
Kalf, Rachel R J, Delnoij, Diana M J, Ryll, Bettina, Bouvy, Marcel L, Goettsch, Wim G, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Journal of Medical Internet Research
Journal of Medical Internet Research, 23(12). Journal of medical Internet Research
Journal of Medical Internet Research, 23(12):e27497. Journal of medical Internet Research
Journal of Medical Internet Research, 23(12). Journal of medical Internet Research
Journal of Medical Internet Research, 23(12):e27497. Journal of medical Internet Research
Background There is a general agreement on the importance of health-related quality of life (HRQoL). This type of information is becoming increasingly important for the value assessment of health technology assessment agencies in evaluating the benef